Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
I give below details of an increase in interests in Ordinary shares in GlaxoSmithKline plc purchased at a price of £13.05 per share on 7 October 2010, and Ordinary share ADRs in GlaxoSmithKline plc purchased at a price of $41.42 per ADR on 7 October 2010, in respect of the personal holdings of the under-mentioned persons following the re-investment of the dividend paid to shareholders on 7 October 2010.
|
Ordinary shares |
ADRs |
Dr M M Slaoui |
144.82 |
131.86 |
Mrs C E Bruck Slaoui |
43.12 |
6.43 |
Mr J M Clarke |
366.54 |
|
Mr M Dunoyer |
175.25 |
|
Mr E J Gray |
206.95 |
|
Mr W C Louv |
|
103.26 |
Mr D J Phelan |
|
252.35 |
Dr D Pulman |
|
155.30 |
Mr D S Redfern |
112.05 |
|
Mr J R Stéphenne |
542.35 |
|
Ms C Thomas |
84.82 |
|
Mr P J T Vallance |
50.73 |
|
The Company was advised of this information on 13 October 2010.
This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
S M Bicknell
Company Secretary
13 October 2010